Health

HPV vaccine gains FDA approval

NEWS IN BRIEF — Posted June 26, 2006

Print  |   Email  |   Respond  |   Reprints  |   Like Facebook  |   Share Twitter  |   Tweet Linkedin

The Food and Drug Administration approved on June 8 the first vaccine to prevent cervical cancer, precancerous genital lesions and genital warts caused by the human papillomavirus, types 6, 11, 16 and 18. It was approved for girls and women ages 9 to 26.

The vaccine, Gardasil, manufactured by Merck & Co., was evaluated and approved in six months via the FDA's priority review process.

Gardasil is a recombinant vaccine given as three injections over a six-month period. It will not eliminate the need for routine Pap screening, as women are not protected if they had been infected with the virus prior to receiving the shot. Also, while it protects against the HPV strains that most commonly lead to disease, it doesn't protect against all types.

Merck tested the safety of the vaccine in about 11,000 people. The most common adverse effects included mild moderate local reaction including pain or tenderness at the site of the injections.

Merck reported five congenital anomalies in babies born to women who conceived within 30 days of receiving the vaccine, prompting monitoring of women who received Gardasil while unknowingly pregnant.

There is also an ongoing study to evaluate the safety and effectiveness of the vaccine in males.

Note: This item originally appeared at http://www.ama-assn.org/amednews/2006/06/26/hlbf0626.htm.

Back to top


ADVERTISEMENT

ADVERTISE HERE


Featured
Read story

Confronting bias against obese patients

■ Medical educators are starting to raise awareness about how weight-related stigma can impair patient-physician communication and the treatment of obesity. Read story


Read story

Goodbye

■ American Medical News is ceasing publication after 55 years of serving physicians by keeping them informed of their rapidly changing profession. Read story


Read story

Policing medical practice employees after work

■ Doctors can try to regulate staff actions outside the office, but they must watch what they try to stamp out and how they do it. Read story


Read story

Diabetes prevention: Set on a course for lifestyle change

■ The YMCA's evidence-based program is helping prediabetic patients eat right, get active and lose weight. Read story


Read story

Medicaid's muddled preventive care picture

■ The health system reform law promises no-cost coverage of a lengthy list of screenings and other prevention services, but some beneficiaries still might miss out. Read story


Read story

How to get tax breaks for your medical practice

■ Federal, state and local governments offer doctors incentives because practices are recognized as economic engines. But physicians must know how and where to find them. Read story


Read story

Advance pay ACOs: A down payment on Medicare's future

■ Accountable care organizations that pay doctors up-front bring practice improvements, but it's unclear yet if program actuaries will see a return on investment. Read story


Read story

Physician liability: Your team, your legal risk

■ When health care team members drop the ball, it's often doctors who end up in court. How can physicians improve such care and avoid risks? Read story

  • Stay informed
  • Twitter
  • Facebook
  • RSS
  • LinkedIn